GUO Xiao-dan,MA Zhen-yu,WANG Chen-jing,et al.Expression and biological role of DCST1-AS1 in non-small cell lung cancer[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(12):1035-1039.
GUO Xiao-dan,MA Zhen-yu,WANG Chen-jing,et al.Expression and biological role of DCST1-AS1 in non-small cell lung cancer[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(12):1035-1039. DOI: 10.11659/jjssx.11E022106.
Expression and biological role of DCST1-AS1 in non-small cell lung cancer
To detect the expression of DCST1-AS1 in non-small cell lung cancer and explore its effect on malignant biological behavior of cancer cells.
Methods
2
The tissues and corresponding adjacent tissues from 65 patients with non-small cell lung cancer were collected, and the normal human bronchial epithelial cells 16HBE and the non-small cell lung cancer cell lines (A549, H1299, H1650 and HCC827) were cultured in vitro. The expression levels of DCST1-AS1 and miR-29b in tissues and cells were detected by RT-qPCR assay, and the correlation between the DCST1-AS1 expression and the clinical characteristics of patients with non-small cell lung cancer were analyzed. A549 cells were divided into the control group, the si-NC group, the si-DCST1-AS1 group, the si-DCST1-AS1+anti-NC group and the si-DCST1-AS1+anti-miR-29b group. The cell proliferation was detected by CCK-8 assay and clone formation assay,the invasion and migration of cells were detected by Transwell; the expression of E-cadherin, Vimentin and N-cadherin was detected by Western blot.
Results
2
The expression of DCST1-AS1 increased and the expression of miR-29b decreased in non-small cell lung cancer tissues and cells (
P
<
0.05). The expression of DCST1-AS1 was correlated with TNM stage, differentiated degree of tissue, lymph node metastasis and pathological types in non-small cell lung cancer patients(
P
<
0.05). Compared with the control group or the si-NC group, the expression of DCST1-AS1, OD value, number of colony-forming cells, migration cells and invasion cells and the expression of Vimentin and N-cadherin in A549 cells of the si-DCST1-AS1 group decreased(
P
<
0.05), while the expression of miR-29b and E-cadherin increased (
P
<
0.05). Knocking down miR-29b could significantly reduce the effect of down-regulation of DCST1-AS1 expression on the malignant biological behavior of A549 cells.
Conclusion
2
DCST1-AS1 is highly expressed in non-small cell lung cancer, knocking down DCST1-AS1 may inhibit the malignant biological behavior of non-small cell lung cancer cells by up-regulating the expression of miR-29b.
Mithoowani H, Febbraro M. Non-small-cell lung cancer in 2022: a review for general practitioners in oncology [J]. Curr Oncol, 2022, 29(3):1828-1839.doi: 10.3390/curroncol29030150http://dx.doi.org/10.3390/curroncol29030150.
Chen Y, Li Z, Chen X, et al. Long non-coding RNAs: from disease code to drug role [J]. Acta Pharm Sin B, 2021, 11(2):340-354.doi: 10.1016/j.apsb.2020.10.001http://dx.doi.org/10.1016/j.apsb.2020.10.001.
Wang C,Meng X,Zhou Y,et al. Long noncoding RNA CTD-2245E15. 3 promotes anabolic enzymes ACC1 and PC to support non-small cell lung cancer growth [J]. Cancer Res, 2021, 81(13):3509-3524.doi: 10.1158/0008-5472.CAN-19-3806http://dx.doi.org/10.1158/0008-5472.CAN-19-3806.
Pang L, Zhang Q, Wu Y, et al. Long non-coding RNA CCAT1 promotes non-small cell lung cancer progression by regulating the miR-216a-5p/RAP2B axis [J]. Exp Biol Med (Maywood), 2021, 246(2):142-152.doi: 10.1177/1535370220961013http://dx.doi.org/10.1177/1535370220961013.
Hu S, Yao Y, Hu X, et al. LncRNA DCST1-AS1 downregulates miR-29b through methylation in glioblastoma (GBM) to promote cancer cell proliferation[J]. Clin Transl Oncol, 2020, 22(12):2230-2235.doi: 10.1007/s12094-020-02363-1http://dx.doi.org/10.1007/s12094-020-02363-1.
Xie Y, Zhao F, Zhang P, et al. miR-29b inhibits non-small cell lung cancer progression by targeting STRN4[J]. Hum Cell, 2020, 33(1):220-231.doi: 10.1007/s13577-019-00305-whttp://dx.doi.org/10.1007/s13577-019-00305-w.
Shen D, Li J, Tao K, et al. Long non-coding RNA MCM3AP antisense RNA1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p [J]. Bioengineered, 2021, 12(1):3525-3538.doi: 10.1080/21655979.2021.1950282http://dx.doi.org/10.1080/21655979.2021.1950282.
Yang Q, Wang M, Xu J, et al. LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling[J].Mol Cancer, 2023,22(1):122. doi: 10.1186/s12943-023-01814-xhttp://dx.doi.org/10.1186/s12943-023-01814-x.
Su YZ, Cui MF, Du J, et al. LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3p[J]. Eur Rev Med Pharmacol Sci, 2020, 24(3):1158-1167.doi: 10.26355/eurrev_202111_27225http://dx.doi.org/10.26355/eurrev_202111_27225.
Tang L, Chen YL, Tang X, et al. Long noncoding RNA DCST1-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by forming a positive regulatory loop with miR-873-5p and MYC[J]. J Cancer, 2020, 11(2):311-323.doi: 10.7150/jca.33982http://dx.doi.org/10.7150/jca.33982.
Chen J, Wu D, Zhang Y, et al. LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma[J]. Clin Sci, 2019, 133(2):367-379.doi: 10.1042/CS20180814http://dx.doi.org/10.1042/CS20180814.
Cho BC, Felip E, Hayashi H, et al. MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer[J]. Future Oncol, 2022, 18(6):639-647.doi: 10.2217/fon-2021-0923http://dx.doi.org/10.2217/fon-2021-0923.
Pastushenko I, Mauri F, Song Y, et al. Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis [J]. Nature, 2021, 589(7842):448-455.doi: 10.1038/s41586-020-03046-1http://dx.doi.org/10.1038/s41586-020-03046-1.
Geng Q, Li Z, Li X, et al. LncRNA NORAD, sponging miR-363-3p, promotes invasion and EMT by upregulating PEAK1 and activating the ERK signaling pathway in NSCLC cells[J]. J Bioenerg Biomembr, 2021, 53(3):321-332.doi: 10.1007/s10863-021-09892-6http://dx.doi.org/10.1007/s10863-021-09892-6.
Li Z, Yue G, Zhang T, et al. LncRNA ADAMTS9-AS1 knockdown restricts cell proliferation and EMT in non-small cell lung cancer[J]. Histol Histopathol, 2021, 36(10):1063-1072.doi: 10.14670/HH-18-347http://dx.doi.org/10.14670/HH-18-347.
Chen B, Gao T, Yuan W, et al. Prognostic value of survival of microRNAs signatures in non-small cell lung cancer[J]. J Cancer, 2019, 10(23):5793-5804.doi: 10.7150/jca.30336http://dx.doi.org/10.7150/jca.30336.
Magalhães M, Jorge J, Gonçalves AC, et al. miR-29b and retinoic acid co-delivery: a promising tool to induce a synergistic antitumoral effect in non-small cell lung cancer cells [J]. Drug Deliv Transl Res, 2020, 10(5):1367-1380.doi: 10.1007/s13346-020-00768-7http://dx.doi.org/10.1007/s13346-020-00768-7.